Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Belmonte M, Cabrera-Cosme L, Øbro NF, Li J, Grinfeld J, Milek J, Bennett E, Irvine M, Shepherd MS, Cull AH, Boyd G, Riedel LM, Chi Che JL, Oedekoven CA, Baxter EJ, Green AR, Barlow JL, Kent DG.
Belmonte M, et al. Among authors: riedel lm.
Exp Hematol. 2024 Jul;135:104246. doi: 10.1016/j.exphem.2024.104246. Epub 2024 May 17.
Exp Hematol. 2024.
PMID: 38763471
Free article.